Health
Inspiration Capital Partners becomes a strategic investor of New Frontier Vitality
HONG KONG, Nov. 10, 2020 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced that private equity funds advised by ICP have become strategic capital partners and investors of New Frontier Vitality ("NFV"), the leading integrated post-acute and geriatric healthcare platform inChina...
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. ABasel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal. "The...
Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy
SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, November 13, at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter 2020, in addition to providing a b...
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...
Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020
SAN DIEGO and TAICANG, SUZHOU, China, Nov. 9, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced thatZhe...
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors
TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit
PISCATAWAY, N.J., Nov. 9, 2020 /PRNewswire/ -- GenScript USA Inc., the world's
leading research reagent provider, announced today that the U.S. Food and Drug
Administration (FDA) has grantedEmergency Use Authorization (EUA)
FTLife Launches "HealthCare 168 Plus" Critical Illness Protector
HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...
OrbusNeich® Medical and P+F Products & Features® announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc.,
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)
TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that they have signed an exclusive agreement with GPCR Therapeutics, Inc. ("GPCR"), a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercial...
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into inJuly 2019 to...
Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine
* Prudent approach and usability are among the top priorities * Efforts are underway to provide the best efficacy for public at large JAKARTA, Indonesia, Nov. 9, 2020 /PRNewswire/ -- In a bid to support the government's plan to develop Covid-19 vaccine inIndonesia, the National Drug and Food ...
SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189 in Rheumatoid Arthritis
* The Data Safety Monitoring Board (DSMB) finds no safety concerns in the 50 mg and 100 mg dose cohorts * Signs of efficacy against rheumatoid arthritis was observed. Thus, the number of patients changing from the severe to the moderate Clinical Disease Activity Index (CDAI) score was higher ...
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 9, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study pr...
For 2020, The World Innovation Summit for Health (WISH) Delivers Leading Speakers and Compelling Discussions via an Immersive Virtual Platform
DOHA, Qatar, Nov. 9, 2020 /PRNewswire/ -- The World Innovation Summit for Health (WISH) returns on15 November, 2020, offering an impressive range of speakers, networking opportunities, discussions and presentations that explore global health challenges, and – all presented through a purpose-built...
Ascentage Pharma to Release Updated Clinical Results of HQP1351 (Olverembatinib) in Drug-Resistant Chronic Myeloid Leukemia in an Oral Presentation at the American Society of Hematology Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Nov. 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the results from two piv...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 311 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 283 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 258 media titles]
2024-05-02 01:21